Andrea Nguyen, PA-C, MS

Andrea Nguyen, PA, shares her clinical pearls on taking care of patients with AD.

Melodie Young NP and Andrea Nguyen, PA look into the future of AD management.

Physician assistant Andera Nguyen shares her experience on combination therapy and class switching.

Melodie Young NP and Andrea Nguyen, PA discuss handling prior authorizations for systemic therapies in AD.

Expert advanced practice providers in dermatology share practical considerations on implementing novel systemic therapies into clinical practice.

Andrea Nguyen, PA shares insight on selecting the appropriate treatment for different patients with AD.

Advanced practice providers in dermatology discuss the key updates on the newly released guidelines on the management of AD and what this means for clinical practice.

Andrea Nguyen, PA reviews the mechanism of action of the biologics available for AD as well as the safety data on these systemic therapies.

Expert advanced practice providers in dermatology talk about the different systemic and biologic therapies that are currently available and in development for AD.

Andrea Nguyen, PA, discusses some of the drawbacks she sees with topical corticosteroid treatment in AD in her practice.

Andrea Nguyen, PA, shares which symptoms are most burdensome to patients with AD.

Expert advanced practice providers in dermatology discuss the diagnosis of atopic dermatitis.

Experts in dermatology share practice pearls to advanced practice providers and community dermatologists for the management of plaque psoriasis.

Jayme M. Heim, MSN, FNP-BC, discusses unmet needs in the treatment landscape of plaque psoriasis.

Douglas DiRuggiero, DMSc, PA-C, reviews how deucravacitinib impacts the quality of life for patients with plaque psoriasis.

Darren West, MPAS, PA-C, shares how often follow-up is required with deucravacitinib therapy in plaque psoriasis.

Andrea Nguyen, PA-C, MS, provides an overview of the safety considerations of deucravacitinib for the treatment of plaque psoriasis.

Experts in dermatology discuss what patients to consider treating with deucravacitinib, as well as comment on the comparative safety and efficacy of other therapies.

Experts in dermatology discuss the importance of deucravacitinib being an expansion of oral treatment modalities for plaque psoriasis, as well as the long-term data.

Jayme M. Heim, MSN, FNP-BC, reviews deucravacitinib as an oral treatment for moderate to severe plaque psoriasis, describing its unique mechanism of action.

Douglas DiRuggiero, DMSc, PA-C, discusses factors that contribute to switching a patient with plaque psoriasis from a topical to a systemic agent.

Darren West, MPAS, PA-C, reviews treatment failure as criteria for advanced practice providers to utilize a step-up treatment approach.

Andrea Nguyen, MS, PA-C, reviews commonly used therapies for the initial treatment of plaque psoriasis.

Jayme M. Heim, MSN, FNP-BC, discusses the various challenges care providers face when selecting treatment for patients with plaque psoriasis.

Douglas DiRuggiero, DMSc, PA-C, shares his approach to building trust in the patient-provider relationship when counseling patients about treatment of plaque psoriasis.

Darren West, MPAS, PA-C, and Douglas DiRuggiero, DMSc, PA-C, talk about how the treatment of plaque psoriasis has changed as understanding of the disease grows.

Experts in dermatology discuss how clinician understanding of plaque psoriasis has evolved over time.

Jayme M. Heim, MSN, FNP-BC, comments on the need for multidisciplinary care providers in light of comorbidities in plaque psoriasis.

Douglas DiRuggiero, DMSc, PA-C, reviews the role of nurse practitioners, physician assistants, and pharmacists in managing plaque psoriasis.